EMGS 45th Annual Meeting
You are invited to attend the New Technologies Special Interest Group meeting, September 15, at 7:00 am. I look forward to seeing you there!
New Technologies Special Interest Group
Leader: Kevin S. Sweder, Syracuse University
We will discuss new approaches to determine biochemical/biological endpoints that may inform mechanistic understanding and toxicological information about environmental, therapeutic, and endogenous exposure to different agents. With the development of new and highly sensitive assays that can measure changes in single molecules or cytokine release in cells, it seems that we should be able to expand our observations of toxicological changes beyond “looking under lampposts.” Although more sensitive assays may identify more liabilities for exposure to endogenous and exogenous agents, they will also provide greater opportunities for ameliorating toxicities in Phase 3 clinical trials, post-marketing populations, and in populations exposed to environmental pollutants.
Election of Co-chair
Spectroscopical Methods of Measuring Cellular Changes Following Exposure to a Compound
Kevin S. Sweder, Syracuse University
The Use of Multiparameter Flow Cytometric Assays for Different Clastogenic, Aneugenic, and Cytotoxic Agents
Jeffrey C. Bemis, Litron Laboratories
Automated Image Analysis for Clastogenic Endpoints
Genotoxicity of Nano Metal Oxides
(preregistration required for SIG meetings) Please contact Rachel at email@example.com if you have not yet registered to attend.